US2022071935A1PendingUtilityA1

Bumetanide analogs, compositions and methods of use

Assignee: NEUROPRO THERAPEUTICS INCPriority: Jan 22, 2009Filed: May 17, 2021Published: Mar 10, 2022
Est. expiryJan 22, 2029(~2.5 yrs left)· nominal 20-yr term from priority
A61P 9/10A61K 31/18A61P 25/24C07D 307/52C07D 239/04C07D 275/02A61P 25/22A61P 25/16C07D 295/084A61K 31/4355C07D 265/30C07D 231/04C07D 233/02C07D 261/02C07D 277/04C07D 263/04A61P 25/30A61P 25/14C07D 237/02A61P 25/00A61P 27/02A61P 25/28A61P 25/18A61P 25/06A61P 35/00C07D 241/04C07D 211/44C07D 279/12A61P 25/08C07C 311/39A61P 27/06
72
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides bumetanide analogs and compositions comprising such analogs. The present invention also provides pharmaceutical compositions containing these bumetanide analogs and methods for their use. These analogs are believed useful for the treatment and/or prophylaxis of conditions that involve the Na+K+Cl− co-transporter or GABAA receptor.

Claims

exact text as granted — not AI-modified
1 - 191 . (canceled) 
     
     
         192 . A method of treating status epilepticus in a patient in need thereof comprising administering a compound of formula X: 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof, wherein: 
         Y is sulfur; 
         Z is nitrogen; 
         each of R 8  and R 9  independently is hydrogen, alkyl, alkenyl, alkylcyano, alkylhalo, alkaryl, alkylheteroaryl, alkylheterocycloalkyl, alkylaminoalkyl, or alkylaminodialkyl; or 
         R 8  and R 9  together with the atom to which they are attached, form a heterocycloalkyl group; and 
         R 10  is hydrogen or alkyl. 
       
     
     
         193 . A method of treating status epilepticus in a patient in need thereof comprising administering a compound 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof. 
       
     
     
         194 . A method of treating status epilepticus in a patient in need thereof comprising administering a compound 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof.

Join the waitlist — get patent alerts

Track US2022071935A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.